MARKET

RVNC

RVNC

Revance
NASDAQ

Real-time Quotes | Nasdaq Last Sale

22.58
+0.24
+1.07%
Opening 11:12 01/29 EST
OPEN
22.32
PREV CLOSE
22.34
HIGH
22.70
LOW
22.25
VOLUME
219.83K
TURNOVER
--
52 WEEK HIGH
23.43
52 WEEK LOW
9.88
MARKET CAP
1.16B
P/E (TTM)
-5.9628
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RVNC and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RVNC News

  • Mizuho Maintains Buy on Revance Therapeutics, Raises Price Target to $39
  • Benzinga.6d ago
  • Will Revance Therapeutics Continue to Surge Higher?
  • Zacks.01/21 10:32
  • 3 “Strong Buy” Biotech Stocks That Can Inject a Healthy Dose of Upside
  • TipRanks.01/19 14:13
  • The Daily Biotech Pulse: Novo Nordisk's Ozempic Receives Label Expansion For Cardiovascular Events, Adcom Disappointment Inflicts Pain On Durect Shares
  • Benzinga.01/17 13:07

More

Industry

Biotechnology & Medical Research
-0.03%
Pharmaceuticals & Medical Research
+0.36%

Hot Stocks

Name
Price
%Change

About RVNC

Revance Therapeutics, Inc. is a clinical-stage biotechnology company. The Company is focused on the development, manufacturing and commercialization of botulinum toxin products for multiple aesthetic and therapeutic indications. Its peptide technology enables delivery of botulinum toxin type A through two investigational drug product candidates, DaxibotulinumtoxinA for Injection (RT002), or RT002 injectable, and DaxibotulinumtoxinA Topical Gel (RT001), or RT001 topical. It is engaged in the clinical development for RT002 injectable. RT002 injectable utilizes botulinum toxin-peptide complex in a saline-based formulation. In RT002 injectable, the peptide interacts with both extracellular structures and cell surface receptors in the targeted muscle. This interaction restricts the toxin molecule to the target site and reduces unwanted spread to other neighboring muscles. It is focusing on developing RT002 for the treatment of glabellar lines, cervical dystonia and plantar fasciitis.
More

Webull offers Revance Therapeutics Inc (RVNC) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.